Medgadget (blog)Synthetic Biology Market to Surpass US$ 56044.9 Mn By 2025Medgadget (blog)Synthetic biology, an interdisciplinary branch of biology and engineering, involves designing and constructing new devices, systems and biological parts as well a… Continue reading
ReasonAdventures in Home Biohacking with CRISPRReasonThis is possible because of CRISPR, a technology that is already revolutionizing food, medicine, and more. CRISPR comprises two key molecules. One is the Cas9 protein, an enzyme that can cut two stra… Continue reading
Science DailySome blood stem cells are better than othersScience DailyIn your body, blood stem cells produce approximately 10 billion new white blood cells, which are also known as immune cells, each and every day. Even more remarkably, if some of thes… Continue reading
Edmonton Sun |
Stem cell registration drives being organized in Edmonton and Calgary to help save student’s life
Edmonton Sun Bille Nguyen needs to find a stem cell match after being diagnosed with a rare form of blood cancer — subcutaneous panniculitis-like T-cell lymphoma. After hearing how difficult it can be to find a match, his elder sisters began organizing stem cell … |
Investor’s Business Daily |
Dow Jones Futures: Amazon Limps Into ‘Friend Zone’; Top Biotech Dives Late
Investor’s Business Daily Dow Jones futures were little changed late Wednesday, along with S&P 500 futures and Nasdaq futures. Gene-editing specialist Crispr Therapeutics (CRSP) crashed after the FDA put a hold on its sickle cell disease treatment with Vertex Pharmaceuticals … |
MIT Technology Review |
FDA halts one of the first human CRISPR studies before it begins
MIT Technology Review FDA hold: But according to a statement on Wednesday from CRISPR Therapeutics, the FDA ordered the company not to proceed with its study until it answers questions about its CRISPR treatment (the company didn’t provide any further details about what … Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldBloomberg CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 …GlobeNewswire (press release) What Makes This CRISPR Stock Better Than the Rest?Motley Fool Xconomy –Boston Business Journal –StreetInsider.com all 22 news articles » |
Calgary Herald |
Sisters holding stem cell registration drive in Calgary to try to save brother
Calgary Herald Three Edmonton sisters are trying to save their brother’s life by encouraging Calgary’s Asian community to participate in a stem cell registration drive on Sunday. Bille Nguyen needs to find a stem cell match after being diagnosed with a rare form of … |